NIH's National Center for Advancing Translational Sciences has disclosed details about the first library of therapeutics in its New Therapeutic Uses for Existing Molecules program. Although it is not yet clear how researchers will use the library of compounds provided by eight pharmas, hints about potential therapeutic avenues can be gleaned from similar compounds in development.